| Rahim Tabriz, MD | |
|
602 W University Ave, Urbana, IL 61801-2530 | |
| (217) 383-3311 | |
| Not Available |
| Full Name | Rahim Tabriz |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 602 W University Ave, Urbana, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245377126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rahim Tabriz, MD 602 W University Ave, Urbana, IL 61801-2530 Ph: (217) 383-3311 | Rahim Tabriz, MD 602 W University Ave, Urbana, IL 61801-2530 Ph: (217) 383-3311 |
News Archive
A new strategy for cancer therapy, which converts the tumor-promoting effect of the immune system's inflammatory response into a cancer-killing outcome, is suggested in research findings by investigators at the University of California, San Diego (UCSD) School of Medicine.
Reporting in Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body.
The Telegraph looks at the upcoming Mobile Health Africa Summit, the first event of its kind where stakeholders across Africa and the world will come together to debate the implementation of m-health across the continent.
Shire plc, the global specialty biopharmaceutical company, announces that it has reached an agreement with the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration to conduct additional clinical trials to confirm the clinical benefit of ProAmatine (midodrine HCl), a medicine approved in 1996 under Subpart H for the treatment of symptomatic orthostatic hypotension (SOH).
A week after the health overhaul cleared Congress, a business lobby that opposed the plan is now regrouping to shape its implementation and exact political retribution on supporters, The Wall Street Journal reports. "The U.S. Chamber of Commerce is planning a broad effort to blunt the health overhaul by trying to shape its regulatory language and spending heavily to unseat vulnerable Democrats who voted for it."
› Verified 4 days ago
Joselyn Joseph, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 W. Park St., Hospitalist, Urbana, IL 61801 Phone: 217-383-3129 Fax: 217-326-1550 | |
Dr. Uday Bhaskar Kanakadandi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Hvi, Urbana, IL 61801 Phone: 217-383-3110 | |
Dr. Nelson Onyekachukwu Okobia, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-549-6585 | |
Robert W. Kirby, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 602 W University Ave, Urbana, IL 61801 Phone: 217-383-3311 | |
Pardeep Kumar Thourani, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Carle Forum, Ll, Urbana, IL 61801 Phone: 217-383-3110 | |
Benjamin J Rhee, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 W. Park St., Cardiology, Urbana, IL 61801 Phone: 217-904-7000 Fax: 217-904-7742 | |
Mr. Mobeen Zaka Haider, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 611 W. Park St. Carle Foundation Hospital, Urbana, IL 61801 Phone: 217-383-3310 |